Association between the rs1800795G>C polymorphism in the promoter of interleukin-6 gene and bladder cancer.
Ontology highlight
ABSTRACT: Interleukin-6 (IL-6) is an inflammatory cytokines that plays a role in the development of cancer. Several studies have examined the relationship between the IL-6 -174G>C polymorphism and bladder cancer, but these results are inconclusive. Therefore, we conducted a meta-analysis to explore the association between IL-6 -174G>C polymorphism and bladder cancer risk. A comprehensive literature search was performed to identify eligible studies regarding the IL-6 -174G>C polymorphism and bladder cancer. Effect sizes under fixed- and random-effects models were calculated using odds ratios (ORs) with 95% confidence intervals (CIs). Finally, five case-control studies were included in the subsequent analyses. In the fixed-effect analysis, significantly higher bladder cancer risks of 1.20 (95% CI = 1.
SUBMITTER: Chiang YT
PROVIDER: S-EPMC6962851 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature
ACCESS DATA